PDB29 PHARMACOECONOMIC CONSEQUENCES OF LOSARTAN THERAPY IN PATIENS UNDERGOING DIABETIC END-STAGE RENAL DISEASE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75007-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)75007-5/fulltext
Title :
PDB29 PHARMACOECONOMIC CONSEQUENCES OF LOSARTAN THERAPY IN PATIENS UNDERGOING DIABETIC END-STAGE RENAL DISEASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75007-5&doi=10.1016/S1098-3015(10)75007-5
First page :
Section Title :
Open access? :
No
Section Order :
932